We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Cracking the CRS Code in Myeloma: Insights from a Comprehensive Case Review
Caitlin Costello, MD
Sagar Lonial, MD, FACP
A Roadmap to Safe and Effective Bispecific Antibody Use in Myeloma: Mitigating and Managing Adverse Events
Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Clinical Challenges With Triple-Class or Penta-Refractory MM
Integrating Bispecific Antibodies Into Clinical Practice
Bispecific Antibodies: The Newest Immunotherapy on the Block for RRMM
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
Considerations for Dosing Bispecific Antibodies
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Efficacy Data for Bispecific Antibodies in RRMM
Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)
Annie Levesque, MD, MSc
Ethan A. Cowan, MD
The Path Forward: What’s On The Horizon?
Manesh R. Patel, MD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education